InCube Ventures

DFJ InCube Ventures, based in San Jose, California, is a specialized venture capital firm dedicated to the life sciences sector. The firm focuses on identifying and funding extraordinary innovations that address significant unmet clinical needs. Their investment scope primarily covers early-stage companies within the medical device, diagnostics, and biotechnology sectors, reflecting a deep commitment to advancing healthcare solutions.

InCube Ventures employs a strategic investment approach, often taking on the role of lead or co-lead investor in funding rounds. They are particularly active in Series A and Series B financing stages. The firm's typical initial investment in a company ranges from $3 million to $10 million, demonstrating a preference for substantial early commitments to promising ventures. This initial capital is designed to help portfolio companies achieve critical milestones and accelerate their development.

Beyond the initial investment, DFJ InCube Ventures is known for reserving significant capital for follow-on investments, often committing up to $15 million to $25 million over a company's lifecycle. This long-term support underscores their dedication to nurturing portfolio companies through various growth phases. The firm has successfully raised and managed several funds, including DFJ InCube Ventures II, which closed at $100 million, and DFJ InCube Ventures III, a $150 million fund, providing a robust financial foundation for their investment activities.

The firm's strategy is deeply rooted in leveraging its extensive network and operational expertise within the life sciences industry to support its portfolio companies. By combining financial backing with strategic guidance, DFJ InCube Ventures aims to help transform innovative scientific concepts into commercially viable products that can significantly improve patient outcomes and reshape the healthcare landscape.